Therapeutic strategy in unresectable metastatic colorectal cancer

Por Chibaudel, Benoist, Tournigand, Christophe, André, Thierry, de Gramont, Aimery
Publicado em 2012

Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer

Por Zaanan, Aziz, Bachet, Jean-Baptiste, André, Thierry, Sinicrope, Frank A.
Publicado no Curr Colorectal Cancer Rep (2014)

Update on Targeted Agents for Adjuvant Treatment of Colon Cancer in 2006

Por de Gramont, Aimery, Larsen, Annette K., Tournigand, Christophe, Louvet, Christophe, André, Thierry
Publicado em 2007

Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review

Por Chibaudel, Benoist, Tournigand, Christophe, Bonnetain, Franck, Richa, Hubert, Benetkiewicz, Magdalena, André, Thierry, de Gramont, Aimery
Publicado no Ther Adv Med Oncol (2015)

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR tr...

Por Bachet, Jean-Baptiste, Chibaudel, Benoist, Bonnetain, Franck, Validire, Pierre, Hammel, Pascal, André, Thierry, Louvet, Christophe
Publicado no BMC Cancer (2015)

Current Status of Adjuvant Therapy for Colon Cancer

Por André, Thierry, Afchain, Pauline, Barrier, Alain, Blanchard, Pierre, Larsen, Annette K., Tournigand, Christophe, Louvet, Christophe, de Gramont, Aimery
Publicado em 2007

Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administere...

Por Bachet, Jean-Baptiste, Peuvrel, Lucie, Bachmeyer, Claude, Reguiai, Ziad, Gourraud, Pierre A., Bouché, Olivier, Ychou, Marc, Bensadoun, Rene J., Dreno, Brigitte, André, Thierry
Publicado em 2012

Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

Por Chibaudel, Benoist, Bonnetain, Franck, Tournigand, Christophe, Bengrine-Lefevre, Leila, Teixeira, Luis, Artru, Pascal, Desramé, Jérôme, Larsen, Annette K., André, Thierry, Louvet, Christophe, de Gramont, Aimery
Publicado em 2011

Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies

Por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Gomi, Katsushige, Lee, Po-Huang, Gramont, Aimery, Rothenberg, Mace L, André, Thierry, Brienza, Silvano, Goldberg, Richard M
Publicado em 2012

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOL...

Por Hamidou, Zeinab, Chibaudel, Benoist, Hebbar, Mohamed, Hug de Larauze, Marine, André, Thierry, Louvet, Christophe, Brusquant, David, Garcia-Larnicol, Marie-Line, de Gramont, Aimery, Bonnetain, Franck
Publicado no PLoS One (2016)

Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies

Por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Lee, Po-Huang, de Gramont, Aimery, Goldberg, Richard M., Rothenberg, Mace L., André, Thierry, Brienza, Silvano, Gomi, Katsushige
Publicado em 2011

The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance...

Por Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel
Publicado no Gastrointest Cancer Res (2014)

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Col...

Por Shah, Manish A., Renfro, Lindsay A., Allegra, Carmen J., André, Thierry, de Gramont, Aimery, Schmoll, Hans-Joachim, Haller, Daniel G., Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.
Publicado no J Clin Oncol (2016)

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi...

Por André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Publicado em 2013

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

Por Chibaudel, Benoist, Bonnetain, Franck, Tournigand, Christophe, de Larauze, Marine Hug, de Gramont, Armand, Laurent-Puig, Pierre, Paget, Jérôme, Hadengue, Alexandra, Notelet, Dominique, Benetkiewicz, Magdalena, André, Thierry, de Gramont, Aimery
Publicado no BMC Cancer (2015)

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

Por Renfro, Lindsay A., Grothey, Axel, Xue, Yuan, Saltz, Leonard B., André, Thierry, Twelves, Chris, Labianca, Roberto, Allegra, Carmen J., Alberts, Steven R., Loprinzi, Charles L., Yothers, Greg, Sargent, Daniel J.
Publicado no J Natl Cancer Inst (2014)

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients

Por Etienne-Grimaldi, Marie-Christine, Milano, Gérard, Maindrault-Gœbel, Frédérique, Chibaudel, Benoist, Formento, Jean-Louis, Francoual, Mireille, Lledo, Gérard, André, Thierry, Mabro, May, Mineur, Laurent, Flesch, Michel, Carola, Elisabeth, de Gramont, Aimery
Publicado em 2010

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCE...

Por Shi, Qian, Andre, Thierry, Grothey, Axel, Yothers, Greg, Hamilton, Stanley R., Bot, Brian M., Haller, Daniel G., Van Cutsem, Eric, Twelves, Chris, Benedetti, Jacqueline K., O'Connell, Michael J., Sargent, Daniel J.
Publicado em 2013